The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Major unmet needs in PTCL
Neha Mehta-Shah, MD, Washington University in St Louis, St Louis, MO, gives an overview of unmet needs in peripheral T-cell lymphoma (PTCL), highlighting the need for novel agents and treatment approaches for patients with relapsed/refractory (R/R) disease. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
